Find clinical trials for Prostate Cancer in Philadelphia, PA
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Prostate Cancer trials near Philadelphia, PA, USA:
of this study is to evaluate the safety, tolerability, and antitumour activity of AZD0754 CAR T-cell therapy in participants with metastatic prostate...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States and 14 other locations
and in combination with abiraterone in participants with metastatic prostate cancer. The study includes dose-escalation and cohort ...
Phase 1, Phase 2
Philadelphia, Pennsylvania, United States of America and 16 other locations
pharmacokinetic (PK), pharmacodynamic (PD), and the preliminary efficacy of JANX007 in adults with metastatic castration-resistant prostate ...
Phase 1
Philadelphia, Pennsylvania, United States and 35 other locations
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potentia ...
Phase 1
Bala-Cynwyd, Pennsylvania, United States and 25 other locations
The primary objectives of this study are to evaluate the safety and tolerability of xaluritamig administered as monotherapy or in combination with an...
Phase 1
Philadelphia, Pennsylvania, United States and 8 other locations
this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate...
Phase 1
Philadelphia, Pennsylvania, United States and 10 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Princeton, New Jersey, United States and 42 other locations
This study seeks to determine the clinical impact of Gene Expression Classifier (GEC) testing in prostate cancer care while also de...
Philadelphia, Pennsylvania, United States and 7 other locations
inhibitor, in Veterans with metastatic castration-resistant prostate cancer (mCRPC) characterized by either mismatch repair deficie...
Phase 2
Philadelphia, Pennsylvania, United States and 12 other locations
The overall aim of the trial is to evaluate the safety, tolerability, and pharmacokinetics (PK) of AMG 509 (monotherapy and in combination with abira...
Phase 1
Philadelphia, Pennsylvania, United States and 57 other locations
Clinical trials
Research sites
Resources
Legal